SCHEMBL380702

SCHEMBL380702

CC(C)[SiH](c1ccccc1)C(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.36
MIF P14174 2/20 0.34
TAAR1 Q96RJ0 4/20 0.33
LMNA P02545 3/20 0.33
SLC6A2 P23975 2/20 0.33
MAOA P21397 2/20 0.33
TSHR P16473 2/20 0.33
ALOX12 P18054 2/20 0.33
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33
ACHE P22303 1/20 0.33
SIGMAR1 Q99720 1/20 0.33
CYP2A6 P11509 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA1 P30542 1/20 0.33
NOS2 P35228 1/20 0.32
ADRA2A P08913 1/20 0.32
ADRA2C P18825 1/20 0.32
CYP2D6 P10635 1/20 0.32
HIF1A Q16665 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fluoride SCHEMBL27639901 0.97 TDP1 (0.35) TDP1MIFTAAR1LMNASLC6A2
SCHEMBL1325645 0.77 TDP1 (0.36) TDP1TAAR1LMNASLC6A2MAOA
SCHEMBL28309934 0.76 MEN1 (0.48) LMNATSHRALDH1A1ATMHSD17B10
SCHEMBL6859086 0.75 TDP1 (0.33) TDP1MIFTAAR1LMNASLC6A2
SCHEMBL21722964 0.74
SCHEMBL8992273 0.74 TDP1 (0.35) TDP1TAAR1LMNASLC6A2MAOA
SCHEMBL15914960 0.74 LMNA (0.38) TDP1TAAR1LMNAMAOATSHR
SCHEMBL3203941 0.72 TDP1 (0.33) TDP1TAAR1LMNASLC6A2MAOA
SCHEMBL7183345 0.72 LMNA (0.34) TDP1LMNATSHRALOX12ADRA2A
SCHEMBL705419 0.72 TDP1 (0.33) TDP1TAAR1LMNASLC6A2MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1096 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3998304-A2 ORGANIC SEMICONDUCTOR COMPOSITIONS SmartKem Limited (GB) 2022-05-18 EP claimed
US-11028386-B2 Morpholino oligonucleotide manufacturing method AJINOMOTO CO., INC. (JP) 2021-06-08 US claimed
EP-2817355-B1 ORGANIC SEMICONDUCTOR COMPOSITIONS SMARTKEM LTD (GB) 2021-03-24 EP claimed
CN-106795186-B Process for preparing morpholino oligonucleotides 味之素株式会社 2021-03-02 CN claimed
EP-2817356-B1 ORGANIC SEMICONDUCTOR COMPOSITIONS SMARTKEM LTD (GB) 2021-02-17 EP claimed
EP-2817354-B1 ORGANIC SEMICONDUCTOR COMPOSITIONS SMARTKEM LTD (GB) 2021-01-13 EP claimed
US-10833274-B2 Organic semiconductor compositions SMARTKEM LIMITED (GB) 2020-11-10 US claimed
EP-2817357-B1 ORGANIC SEMICONDUCTOR COMPOSITIONS SMARTKEM LTD (GB) 2020-11-04 EP claimed
EP-2817351-B1 ORGANIC SEMICONDUCTOR COMPOSITIONS SMARTKEM LTD (GB) 2020-08-26 EP claimed
EP-2817352-B1 ORGANIC SEMICONDUCTOR COMPOSITIONS SMARTKEM LTD (GB) 2020-08-26 EP claimed
EP-2817356-A1 ORGANIC SEMICONDUCTOR COMPOSITIONS Smartkem Limited (GB) 2014-12-31 EP claimed
EP-2817352-A1 ORGANIC SEMICONDUCTOR COMPOSITIONS Smartkem Limited (GB) 2014-12-31 EP claimed
WO-2013124687-A1 ORGANIC SEMICONDUCTOR COMPOSITIONS SMARTKEM LIMITED (GB) 2013-08-29 WO claimed
WO-2013124685-A1 ORGANIC SEMICONDUCTOR COMPOSITIONS SMARTKEM LIMITED (GB) 2013-08-29 WO claimed
WO-2013124684-A1 ORGANIC SEMICONDUCTOR COMPOSITIONS SMARTKEM LIMITED (GB) 2013-08-29 WO claimed
WO-2013124688-A2 ORGANIC SEMICONDUCTOR COMPOSITIONS SMARTKEM LIMITED (GB) 2013-08-29 WO claimed
WO-2013124682-A1 ORGANIC SEMICONDUCTOR COMPOSITIONS SMARTKEM LIMITED (GB) 2013-08-29 WO claimed
WO-2013124683-A1 ORGANIC SEMICONDUCTOR COMPOSITIONS SMARTKEM LIMITED (GB) 2013-08-29 WO claimed
WO-2013124686-A1 ORGANIC SEMICONDUCTOR COMPOSITIONS SMARTKEM LIMITED (GB) 2013-08-29 WO claimed
US-5516871-A Diphenylsiloxane oligomers functionalized at both terminals and methods for the preparation thereof DOW CORNING ASIA, LTD. (JP) 1996-05-14 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11028386-B2 Morpholino oligonucleotide manufacturing method DCLRE1B, RNGTT, RTCB TDP1 1040/4885MIF 1681/4885TAAR1 4592/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.